What Biomarkers Consortium – Bone Quality Project Partners Are Saying

“We are excited to hear that FDA has approved the project’s biomarker qualification plan. It is an important step towards supporting badly needed innovation for an under-treated and under-protected patient population.”

“The ASBMR is proud to financially support this critical initiative. Achieving FDA approval to utilize BMD as a surrogate endpoint in future osteoporosis drug development trials could provide patients with more options to fight a disease that leads to debilitating fractures that cause disability, loss of independence, and even death. It is also likely to attract more researchers to the musculoskeletal field, enabling a new horizon of discoveries to help our patients.” 

“For more than 100 years, U.S. dairy farmers have supported the advancement of science as a means to improve human health. National Dairy Council is proud to support — together with other private and public stakeholders — the Biomarkers Consortium’s Bone Quality Project. Identification and validation of biomarkers for bone strength and changes in bone quality will help further the research and clinical practice to treat osteoporosis.”